Yue Chi

NHC Key Laboratory Of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Effectiveness of etoricoxib on bone microarchitecture in PHO patients: A 12-month longitudinal study assessed by HR-pQCT.

Effectiveness of etoricoxib on bone microarchitecture in PHO patients: A 12-month longitudinal study assessed by HR-pQCT.

Journal: Bone

Published: March 10, 2026

Efficacy of sequential denosumab after teriparatide for 6 months compared with denosumab monotherapy in reducing risk of osteoporotic fractures in patients with new fractures: a multicentre randomised controlled trial (STAND study) protocol.

Efficacy of sequential denosumab after teriparatide for 6 months compared with denosumab monotherapy in reducing risk of osteoporotic fractures in patients with new fractures: a multicentre randomised controlled trial (STAND study) protocol.

Journal: BMJ open

Published: February 26, 2026

Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women.

Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women.

Journal: Frontiers in endocrinology

Published: February 11, 2026

Cost-effectiveness thresholds for initiating osteoporosis treatment in postmenopausal women in China: a microsimulation analysis based on real-world data.

Cost-effectiveness thresholds for initiating osteoporosis treatment in postmenopausal women in China: a microsimulation analysis based on real-world data.

Journal: Archives of osteoporosis

Published: December 15, 2025

Denosumab in pediatric patients with fibrous dysplasia/McCune-Albright syndrome: a single-center, open-labeled study.

Denosumab in pediatric patients with fibrous dysplasia/McCune-Albright syndrome: a single-center, open-labeled study.

Journal: Frontiers in endocrinology

Published: December 07, 2025

Association of body fat distribution with bone mineral density: evidence from observational and mendelian randomization analyses.

Association of body fat distribution with bone mineral density: evidence from observational and mendelian randomization analyses.

Journal: Bone

Published: August 25, 2025

Elevated calcitonin gene-related peptide expression through prostaglandin E2-EP4 receptor pathway in promoting proliferative periosteum formation in primary hypertrophic osteoarthropathy.

Elevated calcitonin gene-related peptide expression through prostaglandin E2-EP4 receptor pathway in promoting proliferative periosteum formation in primary hypertrophic osteoarthropathy.

Journal: Journal of orthopaedic translation

Published: July 18, 2025

The genetic polymorphism of XPR1 associated with Fanconi syndrome in Chinese patients with X-linked hypophosphatemia.

The genetic polymorphism of XPR1 associated with Fanconi syndrome in Chinese patients with X-linked hypophosphatemia.

Journal: Journal of endocrinological investigation

Published: April 19, 2025

A nomogram for predicting surgery outcome of tumor-induced osteomalacia: a case-control study.

A nomogram for predicting surgery outcome of tumor-induced osteomalacia: a case-control study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 01, 2025

Relationship Between Serum Nell-1 Level and Bone Geometry, Bone Microarchitecture in Chinese Postmenopausal Women.

Relationship Between Serum Nell-1 Level and Bone Geometry, Bone Microarchitecture in Chinese Postmenopausal Women.

Journal: International journal of endocrinology

Published: March 17, 2025

Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II study.

Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II study.

Journal: EClinicalMedicine

Published: March 11, 2025

Clinical characteristics of tumor-induced osteomalacia lesions in the neurocranium and intracranial structures.

Clinical characteristics of tumor-induced osteomalacia lesions in the neurocranium and intracranial structures.

Journal: Orphanet journal of rare diseases

Published: January 14, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026